Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive
Source: New York Times
Over the last 12 months, Google’s efforts to use artificial intelligence to accelerate drug design have achieved breakthroughs in mimicking human biology and won its top scientists the Nobel Prize in Chemistry.Now Isomorphic Labs, the division within the software giant meant to develop and commercialize the technology, is taking another big step: raising money from an outside investor.Isomorphic plans to announce…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at New York Times